Business News

Huntsman Corporation Announces Appointment of New Independent Board Member

Tuesday 10. May 2011 - Huntsman Corporation (NYSE: HUN) today announced the appointment of Mary C. Beckerle, Ph.D. as a new independent director to its Board of Directors effective May 5, 2011.

Dr. Beckerle, age 56, serves as chief executive officer and director of the Huntsman Cancer Institute located at the University of Utah (HCI). Dr. Beckerle is an internationally recognized scientist who has served on the Advisory Committee of the National Institute of Health. She also served as President of the American Society for Cell Biology. Dr. Beckerle was the recipient of the prestigious Guggenheim fellowship and is considered by her peers as an international leader in scientific research by serving on the Howard Hughes Medical Institute Board and the National Center for Biological Sciences in India.
Commenting on the appointment, Jon M. Huntsman, Executive Chairman of the Board of Directors of Huntsman Corporation said, “Dr. Beckerle is one of the world’s pre-eminent scientists and executives. As a Board member, she will contribute her talents in many of our areas of research and technology. We are truly honored to elect her as a Director of Huntsman Corporation. “
Dr. Beckerle was appointed to fill the vacancy created by the departure of Marsha J. Evans from the Board and will serve as a Class I director for a term that expires at the Company’s 2014 Annual Meeting of Stockholders. The Huntsman Board now comprises nine directors, six of whom are independent directors.